Métier
Nombre d'employés: 500
Ventes par activité
GBP en Millions | 2021 | Poids | 2022 | Poids | Delta |
---|---|---|---|---|---|
Study Management
43,6
%
| 20 | 44,0 % | 26 | 43,6 % | +26,59 % |
Clinical Trial Acceleration
29,6
%
| 13 | 27,6 % | 17 | 29,6 % | +37,06 % |
Regulatory Solutions
20,4
%
| 10 | 21,8 % | 12 | 20,4 % | +20,22 % |
In Silico Solutions
6,4
%
| 3 | 6,6 % | 4 | 6,4 % | +24,42 % |
Ventes par région
GBP en Millions | 2021 | Poids | 2022 | Poids | Delta |
---|---|---|---|---|---|
United States
59,8
%
| 27 | 58,3 % | 35 | 59,8 % | +31,14 % |
Rest of World
19,6
%
| 8 | 17,8 % | 12 | 19,6 % | +41,40 % |
Europe
15,0
%
| 7 | 16,2 % | 9 | 15,0 % | +18,34 % |
United Kingdom
5,6
%
| 4 | 7,7 % | 3 | 5,6 % | -6,92 % |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Philip Reason
CEO | Chief Executive Officer | 62 | - |
Nigel Goldsmith
DFI | Director of Finance/CFO | 62 | 29/11/11 |
Vince D’Angelo
CMP | Compliance Officer | - | 01/01/88 |
Chief Operating Officer | - | 09/01/17 | |
Gordon Baxter
CTO | Chief Tech/Sci/R&D Officer | 63 | 01/01/11 |
Mark Poggi
SAM | Sales & Marketing | - | 01/01/23 |
Eve Leconte
HRO | Human Resources Officer | - | - |
Adrian Gare
PRN | Corporate Officer/Principal | - | 01/04/10 |
John L. Alarcon
PRN | Corporate Officer/Principal | - | 01/01/19 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Riaz Bandali
BRD | Director/Board Member | 55 | 01/12/21 |
Mike McGoun
BRD | Director/Board Member | 76 | - |
David Gare
CHM | Chairman | 81 | 01/01/69 |
Nigel Goldsmith
DFI | Director of Finance/CFO | 62 | 29/11/11 |
Philip Reason
CEO | Chief Executive Officer | 62 | - |
John Leveille
BRD | Director/Board Member | - | - |
Mary Dolson
BRD | Director/Board Member | - | 09/01/23 |